Original Article
Ecological Momentary Assessment of Fatigue in Patients Receiving Intensive Cancer Therapy

https://doi.org/10.1016/j.jpainsymman.2006.08.007Get rights and content
Under an Elsevier user license
open archive

Abstract

The ability to accurately assess the incidence, intensity, and timing of cancer-related fatigue is important for clinicians attempting to manage this symptom and for researchers evaluating interventions to reduce or alleviate fatigue. This methodological report describes our experiences with ecological momentary assessment (EMA) and discusses its applicability for capturing real-time, real-world assessments of fatigue in patients receiving intensive cancer therapy. This methodological report is part of a larger study examining fatigue and physical activity before and after hematopoietic stem cell transplantation (HSCT). A prospective, repeated measures design was used to assess changes in fatigue three days before and three days after intensive cancer therapy and HSCT. A convenience sample (n = 20 before HSCT, and n = 17 after HSCT) was drawn from two Midwestern academic medical centers. Real-time fatigue was measured with a single-item, global, fatigue intensity scale. Multiple fatigue assessments were conducted throughout each study day. Data were collected electronically, facilitating examination of compliance. Subjects responded to fatigue intensity queries 87% of the time before HSCT and 86% after HSCT. Response rates were not unduly influenced by level of fatigue, time of day, or gender. The study findings demonstrate that it is feasible to use computerized EMA to collect self-report fatigue data in acutely ill oncology patients. Most HSCT patients were able to provide real-time fatigue data even when experiencing multiple side effects from the preparatory regimen. EMA is a novel approach that holds substantial promise for investigating fatigue and other cancer symptoms.

Key Words

Fatigue
ecological momentary assessment
intensive cancer therapy

Cited by (0)

This study was supported by the Oncology Nursing Society Foundation (supported by Ortho Biotech Products); American Cancer Society IRG-99-224; and the Center for Research on Cardiovascular and Respiratory Health (CRCRH), College of Nursing, University of Illinois at Chicago. The CRCRH is supported by the National Institute of Nursing Research, National Institutes of Health, grant # P20 NR07812.